News

EBR: Opportunities in IgG4-RD for novel steroid-sparing therapeutics

John H, Stone MD MPH, Chair of the Steritas Scientific Advisory Board, discusses advances in the diagnosis and treatment of this autoimmune disorder that was classified as a unique disease in 2003.

 

Read the article here.